Rising concerns pertaining to women’s health is pushing growth of the market. Fortune Business Insights in a report, titled “Women’s Health Technology Market Size, Share and Global Trend By Technology Type (Surgical, Diagnostic, Contraceptive, Labor & Delivery, Critical Care), Indication (Cancer, Infertility, Menstruation, Pregnancy, Post-menopausal Syndrome, Pelvic Disorders, Infectious Diseases), End Users (Hospitals, Obstetrics & Gynaecology Clinics, Diagnostics Laboratory, Ambulatory Surgery Centers (ASC)) and Geography Forecast till 2026,” offers a detailed evaluation of drivers encouraging growth in the market. Some of the common health issues endured by women are related to pregnancy, post-menopausal syndrome, and infertility. Women’s health technology is emerging as the next disruptor in the healthcare sector, as this market is no more considered a niche market.
By Technology Type
- Labor & Delivery
- Critical Care
- Post-menopausal Syndrome
- Pelvic Disorders
- Infectious Diseases
By End Users
- Obstetrics & Gynaecology Clinics
- Diagnostics Laboratory
- Ambulatory Surgery Centers (ASC)
- North America (the USA, and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Key Industry Developments
- In April 2019, Chiaro Technology Ltd and Elvie launches the world’s first silent wearable breast pump which is hassle free, and technologically smart.
- In August 2018, NaturalCycles Nordic AB got U.S FDA approval for the first and the only contraceptive app NATURAL CYCLES, that comes with a basal thermometer and a mobile app that prevents pregnancy.
- In August 2018, UE LifeSciences Inc., received U.S.FDA approval for its iBreastExam which is a portable, hand-held device that enables medical professionals to identify breast cancer within few minutes without any pain and radiation exposure.
- In July 2017, Aspect Imaging, received U.S. FDA approval for its EMBRACE Neonatal MRI System designed specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). This system does not require a radiofrequency shielded room and can be kept directly in the NICU environment.
More Trending Topics From Fortune Business [email protected]